Clinical Trials Logo

Filter by:
NCT ID: NCT01945645 Completed - Clinical trials for Type 2 Diabetes Mellitus

Ready to Act - Health Education in People With Hyperglycaemia

Start date: September 2006
Phase: N/A
Study type: Interventional

A pre-randomized study in primary health care was designed to investigate health education in a subpopulation extracted from general practitioners (GPs) in one Danish county in the treatment arm of the ADDITION (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care) study, DK. The overall objective of the 'Ready to Act' health education programme was to support the participants' competences in daily life and act appropriately with respect to their dysglycaemic condition. The achievement of action competence involved four learning objectives: intrinsic motivation, informed decision-making, action experience and social involvement. The programme was delivered in primary care settings (health centre or GP surgeries) by nurses, dieticians, physiotherapists and GPs.

NCT ID: NCT01943903 Completed - Clinical trials for Coronary Artery Disease

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)

PLATFORM
Start date: September 2013
Phase: N/A
Study type: Observational

The objective of the PLATFORM Study is to compare clinical outcomes, resource utilization, and quality of life (QOL) of FFRCT-guided evaluation versus standard practice evaluation in patients with suspected CAD in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in the diagnosis of CAD

NCT ID: NCT01943812 Completed - Pregnancy Loss Clinical Trials

Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation

Start date: December 2013
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare two FET protocols by modifying the substituted FET cycle in order to maintain a higher ongoing positive pregnancy rate and thus reduce the early pregnancy loss. Hypothesis: adding GnRH-agonist to the substituted cycle in FET treatment reduces the early pregnancy loss.

NCT ID: NCT01943578 Completed - Clinical trials for Non Small Cell Lung Cancer

Value of Physical Capacity Tests in Lung Cancer

Start date: September 2013
Phase: N/A
Study type: Observational

The study examines the physical capacity of lung cancer patients assessed with the six minute walk test and handgrip strength. Demographic and selfreported exercise behavior is registered to explore correlations to functional and physical capacity. Assessments are made before first chemotherapy cycle and after fourth chemotherapy cycle, an expected average of 12 weeks between first and second assessment.

NCT ID: NCT01941914 Completed - Keloid Clinical Trials

Calcium Electroporation for the Treatment of Keloids

Start date: August 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of calcium electroporation on keloids.

NCT ID: NCT01941901 Completed - Clinical trials for Cutaneous Metastases

Calcium Electroporation for Treatment of Cutaneous Metastases

Start date: September 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effect of calcium electroporation on cutaneous metastases, and compare calcium electroporation with standard treatment: electrochemotherapy.

NCT ID: NCT01941771 Completed - Breast Cancer Clinical Trials

Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer

XeNa
Start date: June 2012
Phase: Phase 2
Study type: Interventional

The study hypothesis is that metronomic treatment is more efficient than standard treatment.

NCT ID: NCT01941732 Completed - Clinical trials for Erectile Dysfunction

Motor Response to Sildenafil in PD

Start date: November 2003
Phase: Phase 4
Study type: Interventional

Sildenafil (Viagra(R))is widely used by men with Parkinsons Disease (PD) and erectile dysfunction. A number of patients have reported that when they take Sildenafil, their need of anti-PD medication is reduced. We hypotheses that sildenafil increases brain blood flow and hence improves the function of specific brain regions, improving motor function. Motor function and cerebral blood flow of 8 patients will be tested before and after Sildenafil intake and before and after anti-PD medication.

NCT ID: NCT01941355 Completed - Clinical trials for Ischaemic Heart Disease

Trial of Rehabilitation in Phase 1 After Coronary Artery Bypass Grafting

SheppHeart
Start date: September 2013
Phase: N/A
Study type: Interventional

Patients undergoing coronary artery bypass graft surgery often experience a range of problems and symptoms related to the procedure and the underlying heart disease. These problems include anxiety and depressive symptoms, immobility issues, complications such as wound seeping, neck and shoulder pains, interrupted and insufficient sleep. Over the last 2 decades, cardiac rehabilitation has become recognized as a significant component in the continuum of care for persons with cardiovascular disease. Furthermore, cardiac rehabilitation has undergone a significant evolution moving from a focused exercise intervention to a comprehensive disease management program. In Guidelines for Coronary Artery Bypass Graft Surgery cardiac rehabilitation is described to include early ambulation during hospitalisation, and outpatient prescriptive exercise training beginning 6-8 weeks following surgery. Our hypothesis is that physical exercise with moderate intensity and a psycho-educative component as a part of cardiac rehabilitation can begin in early postoperatively during hospitalising. Results from studies on phase 1 rehabilitation in coronary artery bypass graft surgery patients are promising. However, no randomised trials have been conducted, and evidence is therefore lacking. The objective of this pilot trial is to investigate the effect of a phase 1 comprehensive cardiac rehabilitation programme consisting of a psycho-educative component, an exercise-training component including pulmonary training, cycling, neck and shoulder exercises, these in combination plus treatment as usual and treatment as usual in patients who undergo coronary artery bypass grafting. SheppHeartCABG is an investigator-initiated 2 x 2 factorial randomised clinical pilot trial with blinded outcome assessment. Recruitment from one site with 1:1:1:1 central randomisation to phase 1 rehabilitation; 1) exercise-training plus usual care, 2) psycho-educative plus usual care 3) exercise-training and psycho-educative plus usual, 4) usual care alone.

NCT ID: NCT01940419 Completed - Hysterectomy Clinical Trials

Testing of the Drug Tranexamic Acids as Prophylaxis of Bleeding in Benign Surgical Removal of the Uterus

PeTraH
Start date: April 2013
Phase: Phase 4
Study type: Interventional

In Denmark, 4400 women annually undergo hysterectomy on benign background (surgical removal of the uterus). 10% of these women experience bleeding complications. The drug Tranexamic Acid (Cyklokapron) has showed significant reduction of bleeding in relation to other types of surgery. The hypothesis of this study is that Tranexamic Acid could also reduce the operative bleeding associated with benign hysterectomy. The study will be carried out as a randomized, placebo-controlled national multicenter trial